Benzinga | Mar 17, 2021 01:36PM EDT

Biodesix on Tuesday Reported Q4 EPS $(0.25) Beats $(0.44) Estimate, Sales $27.03M Beat $15.45M Estimate

Biodesix (NASDAQ:BDSX) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.44) by 43.18 percent. The company reported quarterly sales of $27.03 million which beat the analyst consensus estimate of $15.45 million by 74.94 percent.